Integrative rare disease biomedical profile based network supporting drug repurposing or repositioning, a case study of glioblastoma

BACKGROUND: Glioblastoma (GBM) is the most aggressive and common malignant primary brain tumor; however, treatment remains a significant challenge. This study aims to identify drug repurposing or repositioning candidates for GBM by developing an integrative rare disease profile network containing he...

Descripción completa

Detalles Bibliográficos
Autores principales: McGowan, Erin, Sanjak, Jaleal, Mathé, Ewy A., Zhu, Qian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10519087/
https://www.ncbi.nlm.nih.gov/pubmed/37749605
http://dx.doi.org/10.1186/s13023-023-02876-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10519087/
https://www.ncbi.nlm.nih.gov/pubmed/37749605
http://dx.doi.org/10.1186/s13023-023-02876-2

Ejemplares similares